More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$1.83B
EPS
4.73
P/E ratio
--
Price to sales
0.21
Dividend yield
4.835%
Beta
0.500353
Previous close
$32.85
Today's open
$32.35
Day's range
$29.61 - $32.50
52 week range
$29.35 - $66
show more
CEO
Chris Caldwell
Employees
450000
Headquarters
Newark, CA
Exchange
Nasdaq Global Select
Shares outstanding
61597304
Issue type
Common Stock
Technology
Software & IT Services
Top 5 Bargain P/B Stocks Investors Should Watch Now
AES joins four other low P/B stocks that screen for value, growth and liquidity, offering investors undervalued picks to watch in February.
Zacks Investment Research • Feb 18, 2026

4 Value Stocks to Buy Now Amid AI-Driven Market Volatility
Value stocks are back in focus as markets remain steady. HRMY, TRIP, AES and CNXC screen cheap on P/CF, offering growth and cash flow strength.
Zacks Investment Research • Feb 18, 2026

Concentrix Prices $600 Million Senior Notes Offering
NEWARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (the “Company”) (NASDAQ: CNXC), a global technology and services leader, today announced that it has priced a public offering of $600 million aggregate principal amount of 6.500% Senior Notes due 2029 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with other available funds, as necessary, to redeem or otherwise repay at or prior to maturity all or a portion of its 6.650% Senior Notes due August 2, 2026 (the “2026 Notes”), of which $800 million aggregate principal amount is outstanding as of the date hereof, and pay related fees and expenses. The Offering is expected to close on February 24, 2026, subject to customary closing conditions.
GlobeNewsWire • Feb 12, 2026

Should Value Investors Buy Concentrix (CNXC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Feb 11, 2026

CNXC vs. BWMN: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Business - Services sector have probably already heard of Concentrix Corporation (CNXC) and Bowman Consulting (BWMN). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • Feb 9, 2026

5 Low Price-to-Book Stocks That Are Worth Watching in February
Low P/B screen spotlights IVZ, HRMY, CNXC, PAX and GPN as undervalued picks with solid growth potential heading into 2026.
Zacks Investment Research • Feb 2, 2026

4 Value Stocks to Consider as Tech Volatility Weighs on Wall Street
Tech turmoil weighs on Wall Street, but CNXC, GPN, HRMY, and UHS stand out with low P/CF ratios and solid growth.
Zacks Investment Research • Jan 30, 2026

Wall Street's Favorite Under-the-Radar AI Stock for 2026
Investors have become more discerning on AI stocks, as many are either too expensive or have not delivered on their AI investments. This AI stock is considered a buy by three-quarters of the analysts that cover it.
The Motley Fool • Jan 29, 2026

Concentrix: Deeply Undervalued With Improving Profitability
Concentrix is rated a 'Buy' due to deep value, strong cash flow, and margin stabilization, trading at a forward P/E of 3.55. CNXC's business is showing higher-quality revenue growth, with a focus on higher-margin, technology-driven services and proprietary AI platform differentiation. Recent margin headwinds appear temporary as operational investments scale, with sequential EBITDA margin improvement and robust free cash flow supporting dividends and buybacks.
Seeking Alpha • Jan 20, 2026

Concentrix - Webhelp Write Off Sinks 2025, Where To Now?
Concentrix (CNXC) is executing a tech-driven transformation, leveraging Gen AI and SaaS to move beyond its traditional call center model. Despite a $1.5bn goodwill impairment and margin compression, CNXC generated robust $626m free cash flow and is guiding for $640m in 2026. Management is aggressively reducing debt, buying back shares (~6% annually), and maintaining a stable 3.6% dividend yield.
Seeking Alpha • Jan 14, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Concentrix Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.